PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-06-21

Date Title Company
21-Jun-2022 mdgroup Proudly Sponsors Gladiator Project Spring Classic Golf Fundraiser to Raise Awareness and Hope for Brain Cancer Research and Support mdgroup
21-Jun-2022 Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design Iktos
21-Jun-2022 Nordic Nanovector to Seek Regulatory Feedback Following its Preliminary Review and Independent Data Evaluation of PARADIGME, its Phase 2b Trial with Betalutin® in R/R Follicular Lymphoma Nordic Nanovector
21-Jun-2022 ANALOG PHARMA AND DIPHARMA ANNOUNCE US FDA APPROVAL OF ABBREVIATED NEW DRUG APPLICATION (ANDA) OF GENERIC NITISINONE CAPSULES (TEMPERATURE STABLE) Analog Pharma
21-Jun-2022 EndoSoft is National Endoscopy Database Iteration 2 (NEDI2) Compliant EndoSoft
21-Jun-2022 Achilles Therapeutics Recognized with the 2022 PING Innovation Award Achilles Therapeutics
21-Jun-2022 Medios AG successfully holds Annual General Meeting 2022 Medios AG
21-Jun-2022 Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001 Relief Therapeutics Holding SA
21-Jun-2022 New Alzheimer's Treatment on Horizon as Dementia Reversed for First Time in Dogs Newswire
21-Jun-2022 Accurate Diagnosis of Brain Tumors Using Artificial Intelligence Karl Landsteiner University of Health Sciences
21-Jun-2022 Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million Gelesis
21-Jun-2022 Eplontersen met co-primary and secondary endpoints in interim analysis of the NEURO-TTRansform Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) AstraZeneca
21-Jun-2022 VIVEbiotech continues the expansion of its lentiviral vector manufacturing capabilities to address the viral vector bottleneck VIVEbiotech
21-Jun-2022 Pre-clinical screening technology could increase cancer test numbers by 50 times University of Strathclyde
21-Jun-2022 New agreement paves way for development of first African-owned COVID-19 vaccine Afrigen Biologics & Univercells
21-Jun-2022 ChargePoint Technology’s new facility expands into Europe ChargePoint Technology
21-Jun-2022 PROpel Phase III trial positive results of Lynparza plus abiraterone in 1st-line metastatic castration-resistant prostate cancer published in New England Journal of Medicine Evidence AstraZeneca
21-Jun-2022 ProtonDx New Rapid Multi-Viral Pathogen Detection System Receives CE-IVD Mark ProtonDx
21-Jun-2022 Alnylam UK and Refugee Action Launch 3-year Corporate ‘Challengers’ Partnership Aimed at Preparing More Refugees for Employment in the UK Alnylam Pharmaceuticals
21-Jun-2022 NorthX Biologics expands to Cell Therapy: Partnership with Alder Therapeutics and new manufacturing site on Karolinska campus NorthX Biologics